ARTICLE | Clinical News
Fibrocell, Intrexon preclinical data
June 15, 2015 7:00 AM UTC
In severe combined immunodeficiency (SCID) mice with human skin grafts, FCX-007 led to no adverse effects in 2- and 6-week toxicology studies. Additionally, Fibrocell said collagen type VII (COL7A1) ...